Bixiye
QP44-17 New Pre-Authorization Form for Botulinum Toxin for Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: Des 05, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2951 - 2960 ee natiijooyinka 3563
Bixiye
QP12-17 Prior Authorization/Pre-Approval Forms Specific to Select Medical Policies
Taariikhda uu dhaqangalayo Barnaamijka: May 31, 2017
Bixiye
QP32-16 Centurion Contracts with BlueLink TPA for Claims Administration Servicesa
Taariikhda uu dhaqangalayo Barnaamijka: Nov 18, 2016
Bixiye
QP34-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Uric Acid Transport 1 (URAT1) Inhibitor
Taariikhda uu dhaqangalayo Barnaamijka: May 15, 2018
Bixiye
QP42-16 Pharmacy Step Therapy Program Name Change for Anticonvulsant Agents and Update on Drugs Subject to This Step Therapy Program
Taariikhda uu dhaqangalayo Barnaamijka: Des 15, 2016
Bixiye
QP22-16 APR-DRG and EAPG Grouper Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2016
Bixiye
QP10-17 Implementation of New Utilization Management Platform
Taariikhda uu dhaqangalayo Barnaamijka: May 15, 2017
Bixiye
QP2-17 Post Hospitalization Additional Benefits for SecureBlue Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2017
Bixiye
QP41-16 Quality Improvement Information Available in Provider Press Publication
Taariikhda uu dhaqangalayo Barnaamijka: Des 15, 2016
Bixiye
QP27-16 Information Available in Provider Press Publication
Taariikhda uu dhaqangalayo barnaamijka: Okt 12, 2016